Literature DB >> 21501362

Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation.

Pascale Pescher1, Thierry Blisnick, Philippe Bastin, Gerald F Späth.   

Abstract

Protozoan parasites of the genus Leishmania are important human pathogens that differentiate inside host macrophages into an amastigote life cycle stage. Although this stage causes the pathogenesis of leishmaniasis, only few proteins have been implicated in amastigote intracellular survival. Here we compare morphology, infectivity and protein expression of L. donovani LD1S grown in host free (axenic) culture, or exclusively propagated in infected hamsters, with the aim to reveal parasite traits absent in axenic but selected for in hamster-derived amastigotes through leishmanicidal host activities. Axenic and splenic amastigotes showed a striking difference in virulence and the ability to cause experimental hepato-splenomegaly in infected hamsters. 2D-DIGE analysis revealed statistically significant differences in abundance for 152 spots, with 14 spots showing fivefold or higher abundance in splenic amastigotes. Proteins identified by MS analysis include the anti-oxidant enzyme tryparedoxin peroxidase, and enzymes implicated in protein and amino acid metabolism. Analysis of parasite growth in vitro in minimal medium demonstrated increased survival of hamster-derived compared with axenic parasites under conditions that mimic the nutrient poor, cytotoxic phagolysosome. Thus, our comparative proteomics analysis sheds important new light on the biochemistry of bona fide amastigotes and informs on survival factors relevant for intracellular L. donovani infection.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501362     DOI: 10.1111/j.1462-5822.2011.01593.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  30 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay.

Authors:  Manu De Rycker; Irene Hallyburton; John Thomas; Lorna Campbell; Susan Wyllie; Dhananjay Joshi; Scott Cameron; Ian H Gilbert; Paul G Wyatt; Julie A Frearson; Alan H Fairlamb; David W Gray
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

Review 3.  Understanding Leishmania parasites through proteomics and implications for the clinic.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Proteomics       Date:  2018-05-02       Impact factor: 3.940

4.  An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages.

Authors:  Jair L Siqueira-Neto; Seunghyun Moon; Jiyeon Jang; Gyongseon Yang; Changbok Lee; Hong Kee Moon; Eric Chatelain; Auguste Genovesio; Jonathan Cechetto; Lucio H Freitas-Junior
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12

5.  Infrared fluorescent imaging as a potent tool for in vitro, ex vivo and in vivo models of visceral leishmaniasis.

Authors:  Estefanía Calvo-Álvarez; Kostantinos Stamatakis; Carmen Punzón; Raquel Álvarez-Velilla; Ana Tejería; José Miguel Escudero-Martínez; Yolanda Pérez-Pertejo; Manuel Fresno; Rafael Balaña-Fouce; Rosa M Reguera
Journal:  PLoS Negl Trop Dis       Date:  2015-03-31

6.  Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.

Authors:  Andrea Nühs; Manu De Rycker; Sujatha Manthri; Eamon Comer; Christina A Scherer; Stuart L Schreiber; Jean-Robert Ioset; David W Gray
Journal:  PLoS Negl Trop Dis       Date:  2015-09-25

7.  Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia.

Authors:  Susanne U Franssen; Yegnasew Takele; Emebet Adem; Mandy J Sanders; Ingrid Müller; Pascale Kropf; James A Cotton
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

8.  High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.

Authors:  Nathalie Aulner; Anne Danckaert; Eline Rouault-Hardoin; Julie Desrivot; Olivier Helynck; Pierre-Henri Commere; Hélène Munier-Lehmann; Gerald F Späth; Spencer L Shorte; Geneviève Milon; Eric Prina
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04

9.  Comparative Life Cycle Transcriptomics Revises Leishmania mexicana Genome Annotation and Links a Chromosome Duplication with Parasitism of Vertebrates.

Authors:  Michael Fiebig; Steven Kelly; Eva Gluenz
Journal:  PLoS Pathog       Date:  2015-10-09       Impact factor: 6.823

Review 10.  A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.

Authors:  Emily Rose Mears; Farrokh Modabber; Robert Don; George E Johnson
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.